News

July 17, 2017 8:27 a.m. ET

Kocal Consulting Corporation Announces Collaboration with South Korea’s Largest Hospital to Develop New Cancer Treatment

November 30, 2016

Kocal Consulting Corporation Celebrates New Consulting Agreement with CZ Biomed Corp to Help Deliver Real Value to Bio-Pharm World

November 11, 2015

CZ BioMed Corp. Announces 2.5 Year Survival of Stage 4 Colon Cancer Patient.
Cancer Free After RVLYSIS

August 26, 2013

CZ BioMed Corp. Announces Successful Reduction of Prostate Cancer Tumors
More Than 50% Using PRO-RVLYSIS®

August 16, 2012

CZ BioMed Corp. Announces Licensing of Key U.S. Patent From The University of Texas Health Science Center at San Antonio Regarding the Use of Respiratory Syncytial Virus (RSV) for Anti-Cancer Oncolytic Treatments

January 25, 2012

Prostate Cancer Trials Underway Overseas PRO-RVLYSIS(R) CZ BioMed Corp.

September 22, 2011

Prostate Cancer Cure United States Patent Application – CZ BioMed Corp.

September 8, 2011

PROGRESS IN PANCREATIC CANCER CURE RESEARCH PANRVLYSIS®

Aug 23, 2011

CZ BioMed Corp. Names Internationally Renowned Dr. Ronald E. Wheeler, M.D. as Medical Director of its Scientific and Medical Advisory Boards

May 3, 2011

BREAST CANCER CURE INTERNATIONAL PATENT APPLICATION # PCT/US2011/000602 CZ BioMed Corp.

Oct 12, 2010 12:23 ET

Research for Cancer Cure — RVLYSIS® CZ BioMed Corp.